???????? Epidemiology of Cancer - PowerPoint PPT Presentation

1 / 88
About This Presentation
Title:

???????? Epidemiology of Cancer

Description:

Epidemiology of Cancer Department of epidemiology Harbin Medical University – PowerPoint PPT presentation

Number of Views:639
Avg rating:3.0/5.0
Slides: 89
Provided by: dell55
Category:

less

Transcript and Presenter's Notes

Title: ???????? Epidemiology of Cancer


1
???????? Epidemiology of Cancer
?????????????? Department of epidemiology
,Harbin Medical University
2
? ? (Status)
  • ????(Cancer)??????????????,?100????????????
    ??,??????????????????????,????????????????????????
    2015?,??????????900?,?????1500?,????????????????

In 201515x106 people suffer from cancer 2/3
in developing country Motility will reach to
9x106
3
?? (Introduction) ???????????? (Study method of
epidemiology) ?????????? (Prevelence states)
4
  • ????????????
  • (Cancer prevelence of China)
  • ?????????
  • (Risk factors of cancer)
  • ???????
  • (Prevention of cancer)

5
??
(Concept)
  • ????????????????????????????,????,???????????
    ?????????

6
Definition
  • (1) Cancer epidemiology is the study of
  • the pattern of cancer in populations.
  • (2) Its essential aim is to identify causes of
    cancer, including preventable (avoidable) causes
    and inherited tumor susceptibility.

7
  • (3) It is also play an critical role in many
  • other areas of cancer research including
  • evaluation of screening effects, cancer
  • prevention and control
  • (4) Current studies directions includes
  • molecular and genetic epidemiology of
  • cancer.

8
??? ? ?(Introduction)
  • ? ?????
  • ?????????????????????????????????

9
(No Transcript)
10
1.??????????(Pathological Features )
  • 1)??(cell) ?????????????????????(differentiatio
    n)?????,????????????????,?????

11
Molecular pathologic Technology and immune
chemistry methods
  • ??????????????DNA?????????????????????????
    ????
  • ????????????????????????????????????,??????
    ????,??????????????????p53????????????????????

12
DNA Technique
  • DNA??????????????????????,???????????????????
    ???????????

13
  • 2)????(Biomarker)???????????????????,???????
    ???????????????????????

14
  • 3)??????????(classification)
  • ??????????????????(T),?????(N)????????????(
    M)3?????????????,??pTNM???
  • ??T????????????,N???????????,M??????????

15
(No Transcript)
16
  • ???????(classification)????????????,????????
    ???????????????????????????????,????????????
  • ???????????3????,????????,???????,??????????
    ?????,???????????3??????????????

17
2.????????????(Biological characteristics)
  • ????(gene expression)?????(Cell cycle
    )?????????????,?????????????????????????????????

18
???????? (Biological characteristics)
  • ???? ?? ?? ???? ??
  • ???? ? ??
  • ??? ? ?? - -
  • ?????????(Immortality ),???(Invasiveness),???(Spre
    ading )

19
???????(Origin of tumor)
  • ?????(Monoclonal theory)
  • ????????????????????????????????????????????
    (stem-cell)????????????,??????? ??
    ??????????(BAC),???,???,?????????????k-ras????????

20
?????(Polyclonal theory)
  • ??????????????????
  • ???????????(Genetic analysis )
  • ?????????????,?APC???Mshz
  • ??????????

21
???????????
(Origin of Single center or Multi center)
  • ?????(???)
  • ???????????????????????,???????????????
  • ?????(???)
  • ?????????????????,?????,???,?????????????????
  • ???????????????

22
??? (Oncogene)
  • ??????????,??????????.
  • ????????????,????????,?????????,??,????,??????????
    ??
  • ??????????????????,?????????DNA????????????????

23
?????(Discovery of oncogene)
  • 1911? Rous???????(RSV)???????????,?????????
  • 1976??RVS??????src??????????,????V-onc?
  • 1982??????????????????ras??????? C-onc?

24
?????(c-onc)
  • 1976?,Bishop?Rous?????????src,????????????????????
    ??????????????????????,?????????????
  • ?????????????

25
??????? (Mechanisms )
  • ???
  • ????ras ??189??????????????????????????,?ras
    gene ???,ras ??????????,?????
  • ras proto-oncogene
  • 1 12 61 189
  • gly gln
  • ?
  • arg ( G ?C), k-ras oncogene

26
??????(Types of Oncogene)
  • abl
  • bcl
  • erb
  • fos
  • myc
  • ras
  • sis
  • src
  • ?100???

27
???????
(Sites of oncogene)
  • Gene c-onc protein v-onc protein
  • src ? ?
  • ras ? ?
  • myc ? ?
  • fps ? ???
  • abl ? ?

28
??????????(Mechanism of Oncogene)
  • ?????
  • ras??12??????,G-T
  • arg-val, ras???GTP??,
  • ?????????
  • ras ????????,????????
  • ras?CCGG???????,?????????

29
ras ?????
(Family members of ras)
  • ??????,??????????,?ras????????
  • H-ras 11p15.5 ?? ??? ???
  • N-ras 1p13.2 ??? ??
  • K-ras 12p12.1 ??? ??? ??

30
????(Cancer-inducing virus)
  • ? ? ???? ???
  • ????? ????DNA T????
  • ??? ????DNA E1A,E1B
  • ???? ????DNA EB??
  • ????? ??RNA ras,src?

31
??????(tumor suppressor gene)
  • ??????????????,??????????,??????????????????????
    ,???????????,???????????????
  • 1968?Harris??
  • ???? X ????
  • ???????
  • ?? ??? (???????)

32
???????????(First discovered Tumor Suppressor
Gene)
  • ???????
  • ??Rb?????????,??????,???????????????????????
    ?Rb?????????Rb???????????????,??Rb????????
  • del(13) (q14)

33
??????????????(Study methods of Cancer
Epidemiology)
  • ??????????,??????,????????????????????,?????
    ???????????????????????????,??????????????????????
    ???,?????????,?????????????????,??????????????????
    ????????

34
???????????????
  • ??????????????????????????????
  • ?????????????????????????????????
  • ??????????????????????????????,???????????????????
    ??????

35
  • ?????????????????????
  • ??????????????????????,???????

36
???????? (Descriptive epidemiologic study)

To describe the difference in occurrence
of a particular cancer between different groups
(age, gender, race, country, a period of time
for time trend) and to generate the hypothesis
for increased/decreased for the specific tumor
type.
37
  • ???????????(health information system,HIS)
    ????????????????????????????????????,?????????????
    ?HIS????????????????????????????????????????????
    ????????,?????????

38
                                                                                                        2004?8?9?856 --
                                                                                                                                                                                                                                                                                                                                                                                                                    
2004/07/15?????????????????????????? ???????????????????????????,??????????????????????????????,?????????????????????(??????),??2004?6?10????????????????????????????????????,????????????????????????????????????????????????????????????????????,?????????????,?????????????????(??????)????????,????????????????????????????? ?????????????????????????,????????????,??????2004??????
39
  • ????????????????,???????????????????????????
    ?,???????????????????????????????,????????????????
    ?????????????

40
  • ??????????????????????????????????,?????????
    ???,??????????????,?????????????

41
???????? (Analytic epidemiological study)
  • ?????????????????????????????????????????
  • ??????????????????????????????????????????????

42
  • ?????????????????????????????????????????NCI?????
    ?1998???,1999????????????,??1997?????????????????
    ???????2000??????????????????????????????????????
    ?,???????????????????????????????????

43
????????
(Experimental epidemiological study)
  • ???????????????,?????????????????????????????

44
  • ??????????????????????,???????????????NCI??
    ???????????????????,??????????????????????????????
    ??????32902?,???????????????????????????????????1
    998???,????2213?,??????????????,??????????????????
    ???????????????????????????,?????????????????,????
    ???????????

45
?????????????
(Biomarker and tumor epidemiological study)
  • ????????????????????????????,???????????????
    ????????????????

46
??????
(Types of Biomarker)
  • ????(In doses )
  • ????????(Biological effective dose)
  • ??????????(Pre-clinical biological effects )
  • ??????(Susceptibility marker )
  • ????????????????

47
Molecular Epidemiology
Breaking Open the Black Box
48
Molecular Epidemiology
Exposure
Disease
Biological Effective Dose (Adducts)
Preclinical Biologic Effect (SCE oncogene TSG
inactivation)
Internal Dose (Agent Metabolite)
49
(No Transcript)
50
  • ??? ?????????
  • (?????????)

Epidemiological Characteristics of Malignancy
51
Measures of Cancer Frequency Incidence
  • number of new cases occurring
  • can be expressed as an absolute number of cases
    per year or as a rate per 100,000 persons per
    year.
  • incidence rate provides approximation to average
    risk of developing a cancer and is necessary to
    compare risk of disease between populations
  • reduction in incidence is the appropriate
    statistics to use when considering impact of
    primary prevention strategies

52
Measures of Cancer Frequency Mortality
  • number of deaths occurring
  • mortality rate is the number of deaths per
    100,000 persons per year
  • mortality rates measure average risk of dying
    from a specific cancer
  • number of deaths is one measure of outcome or
    impact of cancer (product of incidence and
    fatality of a given cancer)
  • Fatality, (1-survival), is probability that an
    individual with cancer will die from it and is
    generally assumed to be most severe sequelae of
    disease

53
  • mortality rate sometimes used as convenient proxy
    measure of the risk of acquiring the disease
    (incidence) when comparing different groups,
    since it is more readily available
  • BUT we need to assume equal survival or fatality
    in the populations being compared
  • most of time this assumption is not correct, so
    it is safer to use mortality as measure of
    outcome rather than occurrence

54
Measures of Cancer Frequency Prevalence
  • NO agreed definition of prevalence of cancer
  • number of persons in a defined population alive
    at a given time who have had cancer diagnosed at
    some time in past
  • overall prevalence not useful for health care
    planning purposes because resource requirements
    for treating newly diagnosed patients are very
    different from those for supporting long-term
    survivors, especially since a large proportion of
    long-term survivors can be considered cured

55
Measures of Cancer Frequency Prevalence
  • partial prevalence limits number of patients to
    those diagnosed during fixed time in past and is
    more useful prevalence measure of cancer burden
  • prevalence for cases diagnosed within 1, 3, 5
    years are likely to be of relevance to different
    stages of cancer therapy initial treatment (1
    year), clinical follow-up (3 years) and cure (5
    years)
  • patients still alive 5 years after diagnosis are
    considered cured since their death rates are
    similar to general population (some exceptions,
    like breast cancer)

56
Other Measurements Survival
  • survival time defined as time that elapsed
    between diagnosis and death
  • most basic measure of patients survival is the
    observed survival
  • 5-year observed survival is percentage of
    patients alive after 5 years of follow-up from
    date of diagnosis

57
Other Measurements Relative Survival
  • deaths from other competing causes will lower the
    observed survival rates and preclude comparison
    between groups where probability of death in the
    general population vary
  • relative survival rate can be calculated to
    avoid this problem
  • relative survival rate is observed survival rate
    in a patient group divided by expected survival
    of a comparable group in the general population
    with respect to age, sex, and calendar period of
    investigation

58
Other Measurements PYLL
  • Potential Years of Life Lost (PYLL) measures how
    many years of normal life span are lost due to
    deaths from cancer
  • takes into account both number of deaths and age
    at which death occurs
  • Age-weighting function used to increase the
    relative value of adults in productive ages,
    i.e., 1 year saved for someone at 20 years old is
    valued more than for a person aged 60 years
  • varying weighting functions can be given
    according to quality of these life-years

59
  • ?????????
  • (Distribution of cancer)

(?)???? ???????,???????????????,??????????
,????????????????????????,2020?????80?,????????200
0?,??1200?,??????????????,???????????????
60
  • ?????,??????????????22?2000?????????1010?,?
    ?620?????????,??????????????????,?????????????,???
    ?120?,??110??

In the past 10 years, the prevelence and
mortality of cancer increased to 22.new cases
were 10.1million in 2000,and 6.2 million died.
61
  • ????????????????????????????????????????????
    ????????????????????50/10?????10??,???????????,???
    ??????????????,????????,??????????????

62
  • ?????,?????????????????1990?,???????????????
    ???,??10????,8???????????????????????????????????
    ???????????,???????????????????

63
(No Transcript)
64
The lung cancer epidemic - UK
65
The lung cancer epidemic - Canada
66
(No Transcript)
67
(No Transcript)
68
(No Transcript)
69
(No Transcript)
70
(No Transcript)
71
(No Transcript)
72
Tobacco Use in the US, 1900-1999
Per capita cigarette consumption
Male lung cancer death rate
Female lung cancer death rate
Age-adjusted to 2000 US standard
population. Source Death rates US Mortality
Public Use Tapes, 1960-1999, US Mortality
Volumes, 1930-1959, National Center for Health
Statistics, Centers for Disease Control and
Prevention, 2001. Cigarette consumption Us
Department of Agriculture, 1900-1999.
73
(No Transcript)
74
???????????? (Prevelence tendency in China)
  • ??????????????20??????????,?????????????20?
    ?70???84.58/10????20??90???94.36/10?,???11.56?
  • ????????????????????,??????????????????????
    ???????111.85?
  • ??????69.00????1980??????????????,?1985??
    ??????,????6,?????????44???

75
(No Transcript)
76
  • ????????????????????????????
  • 1.?????????????? ?????????????????????????,?????
    ??,???????????,????????????????,????????????

77
  • 2.??????? ?????????,?????????????????????????????
    ???
  • 3.????????????????,????????????,??????????,???????
    ?,???????????????????????????????????

78
????(Risk factors)
  • Biological factors
  • Psycho-social factors
  • ?????
  • ??????
  • ???????
  • ??????
  • Genetic susceptibility factors
  • Environmental physical
  • and chemical factors

79
?????? ????(physical factors) ????(??????)
????(chemical factors) ?? ?? ????
????????????? ???? ????
80
???????(biological factors) ?? HBV HCV
HP HPV EB?? HTLV HIV ??
???? ??? ?????(schistosoma
haematobium)??? ???????(clonorchis
sinensis)????? ?????(schistosoma
japonicum)???
81
?????? (Psycho-social factors)
  • ?????????????
  • ????,????
  • ????,????
  • ????,???????
  • ????,????

82
??????? (Genetic susceptibility factors)
  • ??????
  • ??????
  • ?????

83
???????(Prevention of Cancer)
84
  • ??????

(Prevention strategy)
  • ?????????????
  • ??????????????
  • ???????
  • ?????????????

85
??????(preventive measures)
???? Primary prevention ???? Secondary
prevention ???? Tertiary prevention
86
  • ????
  • ?????????
  • ?????????
  • ?????????
  • ????

(Primary prevention)
87
  • ????
  • ?????
  • ???????????

(Secondary prevention)
88
????
(Tertiary prevention)
  • ?????????????????
  • ????
  • ?????????????
  • ????????,??????????????
Write a Comment
User Comments (0)
About PowerShow.com